,0
Name,"INTERCEPT PHARMACEUTICALS, INC."
Currency,USD
Sector,Healthcare
Industry,Biotechnology
Country,US
IPO,"Oct 11, 2012"
Insider Percentage,17.50%
Institution Percentage,78.65%
